Olivier Voinnet, a researcher at ETH in Zurich and the winner of the 2013 Rössler Prize, is correcting a number of papers following critiques of more than a dozen of his studies on PubPeer.
The work appears in journals including Cell and PNAS. Voinnet’s co-author on several of the papers, David Baulcombe, who is also highly decorated, left this comment on relevant PubPeer entries: Continue reading Award-winning plant researcher correcting several papers critiqued on PubPeer
Ariel Fernandez‘s list of papers with editorial asterisks next to them grew again this week.
Fernandez has had one paper retracted, two papers subject to Expressions of Concern, including one from Nature, and another put on hold over data concerns. He threatened to sue us for covering one of the Expressions of Concern.
Here’s the “Notice from PLOS Genetics” for “Protein Under-Wrapping Causes Dosage Sensitivity and Decreases Gene Duplicability:”
Please be advised that PLOS is working with the authors on an investigation regarding one or more issues that have been raised with respect to the content or authorship of this paper.
We asked Fernandez for more details. He did not provide any, saying only that the criticisms of the work “have no scientific value” because they were made anonymously: Continue reading PLOS Genetics investigating paper by Ariel Fernandez
Two solar cell researchers at the University of New South Wales have lost a paper in Renewable and Sustainable Energy Reviews after the discovery of “substantial overlap” with work by a UNSW graduate student.
The notice cites three sources for the plagiarism. One is an unpublished manuscript by UNSW student Matthew Wright, which he shared with the authors of the retracted paper for “research collaboration only.”
The other two are papers that Wright wrote with UNSW professor Ashraf Uddin, who co-authored the retracted paper with UNSW researcher Xiaohan Yang. Yang’s name also appears on one of the plagiarized papers. All of that suggests that the “substantial overlap” includes duplication as well as plagiarism.
According to Wright’s Google Scholar profile, Uddin has been a co-author on every one of his papers, suggesting that Uddin is Wright’s thesis advisor or P.I., though neither Wright nor Uddin responded to our emailed questions.
Here’s the notice for “Effect of thermal annealing on P3HT:PCBM bulk-heterojunction organic solar cells: A critical review”: Continue reading Solar paper retracted after plagiarism and duplication come to light
A group of Chinese cardiologists at Capital Medical University have done a quick ewe-turn, pulling a paper after mixing up both the author order and wrongly reporting how many sheep were killed in the making of this experiment.
We covered another retraction from the CMU cardiology department in September. The sheep paper was published in October.
Here’s the notice for “Mosaic tissue-engineered porcine pulmonary artery valved conduit: long-term follow-up after implantation in an ovine model”: Continue reading A ewe-turn: Researchers lose sleep, and paper, over miscounted sheep
A group of scientists at Takeda Pharmaceutical, including vice president Yoshinori Ikeura, has lost a paper after realizing that their “novel” compound had been previously synthesized by another Takeda researcher.
The 2011 paper, published in Elsevier journal Bioorganic & Medicinal Chemistry, was the subject of a 2012 corrigendum adding two authors to the paper. The retraction appeared online in December of this year.
Seems like they didn’t add enough authors, though. Continue reading Takeda group retracts paper after realizing “novel” compound had already been synthesized…by a colleague
In April 2014, we wrote about the case of a former hydrologist at the University of Kansas (KU), Marios Sophocleous, who had plagiarized in at least seven studies, two of which were retracted by the journal Ground Water.
At the time, we mentioned two other articles, in the Hydrogeology Journal, that appeared destined for retraction — not least because KU requested that the journal yank them. But in a rather surprising move, the journal is declining to do so, and another publication, the Journal of Hydrology, is taking the same approach.
Here’s the notice from Hydrogeology Journal editor Clifford Voss: Continue reading Water under the bridge? Hydrology journals won’t retract plagiarized papers despite university request
A paper in Food Chemistry suggesting cranberry extract has healing properties was retracted after some of the authors complained they had no idea the paper was being published.
Here’s the notice for “Phenolic composition, antioxidant properties, and endothelial cell function of red and white cranberry fruits:” Continue reading Paper on cranberries’ health benefits retracted after researcher forges authors’ names
Researchers at the University of Pittsburgh have retracted a paper on using thalidomide, which led to an estimated 10,000 birth defects by the time the drug was pulled from the market in 1961, to prevent chemo-induced sterility.
Alkylating agents, which prevent DNA replication in cells, are a commonly-used cancer treatment. Unfortunately they also damage the ovaries and testes, sometimes causing infertility. The University of Pittsburgh scientists published a paper in Elsevier journal Fertility and Sterility in 2011 that suggested thalidomide, which causes severe birth defects when used during pregnancy, might help protect ovaries during chemo.
However, according to the notice, the authors tried and failed to replicate their results. They had two separate scientists who were not authors take a look at the results; everyone agreed that the original study incorrectly reported the number of primordial follicles, the precursor to mature eggs.
Here’s the notice for “Thalidomide treatment attenuates chemotherapy-induced gonadal toxicity”: Continue reading Thalidomide paper retracted for lab error
A major scandal in Japan over the Novartis hypertension drug valsartan has resulted in a retraction from the Journal of Human Hypertension.
Frequent Retraction Watch subject Hiroaki Matsubara resigned his post at Kyoto Prefectural University in 2013, after his work on valsartan was shown to be riddled with data errors and undisclosed conflicts of interest.
Also that year, suspicions about Chiba University hypertension researcher Issei Komuro’s work were first raised by an anonymous blog, which detailed numerous image manipulations in the researcher’s published works. Komuro, who frequently collaborated with Matsubara, has been a senior author on a number of valsartan papers, including the now-retracted one, which reported the results of Novartis-sponsored Valsartan Amlodipine Randomized Trial in 2011 without reporting the Novartis funding.
The paper, which has been cited three times, according to Thomson Scientific’s Web of Knowledge, had already been subject to a correction in 2013: Continue reading Can’t spell Novartis without VART: Drug study retracted for conflict of interest, data issues
A paper arguing that HIV does not cause AIDS has been retracted a few weeks after Jeffrey Beall, who tracks predatory publishers, called attention to it on his blog.
Here’s what Beall wrote about the paper on December 16:
The article is entitled “Basic Principles Underlying Human Physiology” [1], and you don’t have to be a scientist to know that it’s junk, for it is a manifestation of AIDS denialism. The conclusion’s first paragraph says,
HIV is not etiologically involved in AIDS. It is just a common retrovirus found in AIDS conjuncturally. There is only AIDS that may not be strictly associated neither to a primary immune deficiency nor to an acquired immune deficiency. Actually, heart failure represents the causal factor of AIDS and many other “primary” immune deficiencies (p. 1821).
Now, in that article’s place, this retraction, dated December 19, appears: Continue reading AIDS denialism paper retracted after Jeffrey Beall draws attention to it